abstract |
FIELD OF THE INVENTION The present invention relates to the field of blood coagulation and, more specifically, directly to patients in need of treatment, a factor Xa inhibitor is administered once daily in oral dosage form, wherein the factor Xa inhibitor has a plasma concentration half-life index of twice or 1 day. It relates to a method for treating thromboembolic disease, which is three administration intervals per day, for example 10 hours or less. |